GlaxoSmithKline Newsroom

GSK Analyst Ratings

Benzinga01:59

Jefferies Maintains Buy on GSK, Raises Price Target to $53

Benzinga01:59

J.P. Morgan Keeps Their Sell Rating on GlaxoSmithKline (GSK)

TipRanksJul 2 15:08

GlaxoSmithKline (GSK) Gets a Hold From Goldman Sachs

TipRanksJul 1 21:34

Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc

MT NewswiresJun 4 13:20

GSK Analyst Ratings

BenzingaMay 30 18:45

Goldman Sachs Initiates Coverage On GSK With Neutral Rating, Announces Price Target of $47

BenzingaMay 30 18:45

GlaxoSmithKline (GSK) Gets a Buy From Jefferies

TipRanksMay 13 20:35

Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc

MT NewswiresMay 2 13:10

Analysts Offer Insights on Healthcare Companies: Agilent (A), GlaxoSmithKline (GSK) and Stryker (SYK)

TipRanksApr 17 22:45

Analysts Have Conflicting Sentiments on These Healthcare Companies: EBOS Group Limited (AU:EBO), Craneware (GB:CRW) and GlaxoSmithKline (GB:GSK)

TipRanksMar 5 17:04

GSK Analyst Ratings

BenzingaMar 4 18:56

Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc

MT NewswiresFeb 1 13:10

Morgan Stanley Initiates GSK at Equal-Weight Rating With $44 Price Target

MT NewswiresJan 25 01:01

GSK Analyst Ratings

BenzingaJan 23 19:44

Jefferies Upgrades GSK to Buy, Raises Price Target to $48

BenzingaJan 3 18:46

GSK Analyst Ratings

BenzingaJan 3 18:44

Berenberg Bank Adjusts GSK Price Target to $41 From $44, Maintains Buy Rating

MT NewswiresNov 8, 2023 20:46

Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc

MT NewswiresNov 2, 2023 14:20

Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc

MT NewswiresOct 13, 2023 18:00